Literature DB >> 12897770

Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase.

Sabine Breinig1, Jukka Kervinen, Linda Stith, Andrew S Wasson, Robert Fairman, Alexander Wlodawer, Alexander Zdanov, Eileen K Jaffe.   

Abstract

Porphobilinogen synthase (PBGS) catalyzes the first common step in the biosynthesis of tetrapyrroles (such as heme and chlorophyll). Although the predominant oligomeric form of this enzyme, as inferred from many crystal structures, is that of a homo-octamer, a rare human PBGS allele, F12L, reveals the presence of a hexameric form. Rearrangement of an N-terminal arm is responsible for this oligomeric switch, which results in profound changes in kinetic behavior. The structural transition between octamer and hexamer must proceed through an unparalleled equilibrium containing two different dimer structures. The allosteric magnesium, present in most PBGS, has a binding site in the octamer but not in the hexamer. The unprecedented structural rearrangement reported here relates to the allosteric regulation of PBGS and suggests that alternative PBGS oligomers may function in a magnesium-dependent regulation of tetrapyrrole biosynthesis in plants and some bacteria.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12897770     DOI: 10.1038/nsb963

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  44 in total

Review 1.  Structure and function of enzymes in heme biosynthesis.

Authors:  Gunhild Layer; Joachim Reichelt; Dieter Jahn; Dirk W Heinz
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

2.  ALAD porphyria is a conformational disease.

Authors:  Eileen K Jaffe; Linda Stith
Journal:  Am J Hum Genet       Date:  2006-12-21       Impact factor: 11.025

3.  Expanding the Concepts in Protein Structure-Function Relationships and Enzyme Kinetics: Teaching using Morpheeins.

Authors:  Sarah H Lawrence; Eileen K Jaffe
Journal:  Biochem Mol Biol Educ       Date:  2008       Impact factor: 1.160

4.  Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.

Authors:  Bashkim Kokona; Daniel J Rigotti; Andrew S Wasson; Sarah H Lawrence; Eileen K Jaffe; Robert Fairman
Journal:  Biochemistry       Date:  2008-09-17       Impact factor: 3.162

5.  Crystal structure of Toxoplasma gondii porphobilinogen synthase: insights on octameric structure and porphobilinogen formation.

Authors:  Eileen K Jaffe; Dhanasekaran Shanmugam; Anna Gardberg; Shellie Dieterich; Banumathi Sankaran; Lance J Stewart; Peter J Myler; David S Roos
Journal:  J Biol Chem       Date:  2011-03-07       Impact factor: 5.157

6.  Impact of quaternary structure dynamics on allosteric drug discovery.

Authors:  Eileen K Jaffe
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

7.  The activation mechanism of human porphobilinogen synthase by 2-mercaptoethanol: intrasubunit transfer of a reserve zinc ion and coordination with three cysteines in the active center.

Authors:  Nori Sawada; Noriyuki Nagahara; Tadashi Sakai; Yoshiaki Nakajima; Masayasu Minami; Tomoyuki Kawada
Journal:  J Biol Inorg Chem       Date:  2005-03-04       Impact factor: 3.358

8.  Allosteric Regulation of Oligomerization by a B12 Trafficking G-Protein Is Corrupted in Methylmalonic Aciduria.

Authors:  Markus Ruetz; Gregory C Campanello; Liam McDevitt; Adam L Yokom; Pramod K Yadav; David Watkins; David S Rosenblatt; Melanie D Ohi; Daniel R Southworth; Ruma Banerjee
Journal:  Cell Chem Biol       Date:  2019-05-02       Impact factor: 8.116

9.  Analysis of the link between enzymatic activity and oligomeric state in AhpC, a bacterial peroxiredoxin.

Authors:  Derek Parsonage; Derek S Youngblood; Ganapathy N Sarma; Zachary A Wood; P Andrew Karplus; Leslie B Poole
Journal:  Biochemistry       Date:  2005-08-09       Impact factor: 3.162

10.  Porphobilinogen synthase from the butterfly, Pieris brassicae: purification and comparative characterization.

Authors:  Roland Rilk-van Gessel; Hartmut Kayser
Journal:  J Insect Sci       Date:  2007       Impact factor: 1.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.